Exact Sciences Corporation (NASDAQ:EXAS)
Exact Sciences Corporation (NASDAQ:EXAS) represented a move of -4.17 percent or $2.59 per share and closed its previous day trading session at $60.41. 1.87 Million Shares were traded in the last trading session with an Average Volume of 2.28 Million Shares. The stock currently has a Market Capitalization of 7.64 Billion.
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
The stock traded between $37.36 and $81.22 over 1-Year time period showing its price to sales ratio of 21.62. Exact Sciences Corporation (NASDAQ:EXAS) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-13.42 and 200-Day Simple Moving Average of $5.76. Its Price to Free Cash Flow is 0 and Price to Book of 9.9.
Analyst’s recommended the stock as 1.8 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Exact Sciences Corporation (NASDAQ:EXAS) reported its Actual EPS of $-0.3/share. The analysts offering Earnings Estimates for the company were believing that Exact Sciences Corporation could bring EPS of $-0.32/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 6.3 Percent.
Celanese Corporation (NYSE:CE)
In the last trading session, Celanese Corporation (NYSE:CE) added its value by -6.72% closing at the price of $93.36. The stock currently has market capitalization of 12.66 Billion, with average volume of 1.01 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Celanese Corporation (NYSE:CE) is showing beta of 1.39. This particular value of beta suggests that Celanese Corporation (NYSE:CE) has historically moved 139% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Celanese Corporation (NYSE:CE) is at $8.45.
The stock currently has RSI of 23.02. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Celanese Corporation is a technology company. It engaged in the production of specialty materials and chemical products which are used in industries and consumer applications. The Company offers products which include acetyl, acetate, vinyl emulsion and engineered polymers. It operates primarily in North America, Europe and Asia. Celanese Corporation is based in Irving, United States.
Celanese Corporation (NYSE:CE) topped its 52-week high price of $119.29 on 08/28/18 and 52-Week Low Price of $ 93.10 on 10/24/18. The Stock currently has P/E (price to earnings ttm) of 11.05 and Weekly volatility of 4.65% and monthly volatility of 2.99% respectively.